Zosano Pharma to Present at the BTIG Biotechnology Conference 2020
August 03 2020 - 4:05PM
Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage
biopharmaceutical company, today announced that its president and
chief executive officer, Steven Lo, will present a company overview
at the BTIG Biotechnology Conference 2020 on Tuesday, August 11,
2020 at 3:00 pm ET.
A live webcast of the event will be available on the company’s
website at http://ir.zosanopharma.com/events-presentations. The
archived webcast will remain available for 30 days following the
date of the presentation.About Zosano PharmaZosano
Pharma Corporation is a clinical-stage biopharmaceutical company
focused on developing products where rapid administration of
approved molecules with established safety and efficacy profiles
may provide substantial benefit to patients, in markets where
patients remain underserved by existing therapies. The company’s
transdermal microneedle system technology consists of titanium
microneedles coated with drug that are designed to enable rapid
systemic administration of therapeutics to patients. Zosano’s lead
product candidate is Qtrypta™ (M207), which is a proprietary
formulation of zolmitriptan delivered via its transdermal
microneedle system technology, as an acute treatment for migraine.
The company anticipates that many of its current and future
development programs may enable the company to utilize a regulatory
pathway that has the potential to streamline clinical development
and accelerate the path towards commercialization. Learn more at
www.zosanopharma.com.
Zosano Contact:Christine MatthewsChief
Financial Officer(510) 745-1200
PR Contacts:Sylvia Wheeler or Alexandra
Santosswheeler@wheelhouselsa.com or asantos@wheelhouselsa.com
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Zosano Pharma (NASDAQ:ZSAN)
Historical Stock Chart
From Sep 2023 to Sep 2024